COVID-19/Flu Study
The purpose of this study is to find out how often health problems occur after a COVID-19 and/or Influenza vaccine.
Location: British Columbia, Alberta, Ontario, Quebec, Nova Scotia, PEI, and Yukon Territory.
The Canadian National Vaccine Safety (CANVAS) network’s COVID-19/Flu Study conducts active safety surveillance for COVID-19 and seasonal influenza vaccines.
The primary objective of the COVID-19/Flu Study is to monitor the safety of COVID-19 and influenza vaccines by tracking and comparing health events in vaccinated and unvaccinated groups.
Study participants will receive an email 8 days and one month after they received their COVID-19 and/or influenza vaccination inviting them to respond to an online survey.